{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:35:44Z","timestamp":1789734944852,"version":"4.0.1"},"reference-count":115,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T00:00:00Z","timestamp":1695513600000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic lymphocytic leukaemia (CLL) is the most common haematological malignancy in Australia and New Zealand (ANZ). Considerable changes to diagnostic and management algorithms have occurred within the last decade. The availability of next\u2010generation sequencing and measurable residual disease assessment by flow cytometry allow for advanced prognostication and response assessments. Novel therapies, including inhibitors of Bruton's tyrosine kinase (BTKi) and B\u2010cell lymphoma 2 (BCL2) inhibitors, have transformed the treatment landscape for both treatment\u2010na\u00efve and relapsed\/refractory disease, particularly for patients with high\u2010risk genetic aberrations. Recommendations regarding appropriate supportive management continue to evolve, and special considerations are required for patients with CLL with respect to the global SARS\u2010CoV\u20102 pandemic. The unique funding and treatment environments in Australasia highlight the need for specific local guidance with respect to the investigation and management of CLL. This consensus practice statement was developed by a broadly representative group of ANZ experts in CLL with endorsement by peak haematology bodies, with a view to providing this standardised guidance.<\/jats:p>","DOI":"10.1111\/imj.16207","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T22:09:57Z","timestamp":1695593397000},"page":"1678-1691","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Chronic lymphocytic leukaemia Australasian consensus practice statement"],"prefix":"10.1111","volume":"53","author":[{"given":"Mary A.","family":"Anderson","sequence":"first","affiliation":[{"name":"Department of Clinical Haematology The Royal Melbourne Hospital and The Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Division of Blood Cells and Blood Cancer The Walter and Eliza Hall Institute  Melbourne Victoria Australia"},{"name":"Department of Medical Biology The University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-4536","authenticated-orcid":false,"given":"Rory","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology The Royal Melbourne Hospital and The Peter MacCallum Cancer Centre  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Badoux","sequence":"additional","affiliation":[{"name":"St George Hospital  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Best","sequence":"additional","affiliation":[{"name":"Flinders University and Medical Centre  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Chia","sequence":"additional","affiliation":[{"name":"Genomic Diagnostics Healius Pathology  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-1399","authenticated-orcid":false,"given":"Tara","family":"Cochrane","sequence":"additional","affiliation":[{"name":"Gold Coast University Hospital Griffith University  Gold Coast Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Cull","sequence":"additional","affiliation":[{"name":"Sir Charles Gairdner Hospital PathWest Laboratory Medicine and University of Western Australia  Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Crassini","sequence":"additional","affiliation":[{"name":"Mid North Coast Cancer Institute Coffs Harbour Health Campus  Coffs Harbour New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Harrup","sequence":"additional","affiliation":[{"name":"Cancer and Blood Services Royal Hobart Hospital  Hobart Tasmania Australia"},{"name":"Menzies Research Institute University of Tasmania  Hobart Tasmania Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Jackson","sequence":"additional","affiliation":[{"name":"Te Whatu Ora health New Zealand Counties Manukau  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryone","family":"Kuss","sequence":"additional","affiliation":[{"name":"Flinders University and Medical Centre  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7971-4003","authenticated-orcid":false,"given":"Masa","family":"Lasica","sequence":"additional","affiliation":[{"name":"St Vincent's Hospital  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Lew","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology The Royal Melbourne Hospital and The Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Division of Blood Cells and Blood Cancer The Walter and Eliza Hall Institute  Melbourne Victoria Australia"},{"name":"Department of Medical Biology The University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2512-917X","authenticated-orcid":false,"given":"Paula","family":"Marlton","sequence":"additional","affiliation":[{"name":"Department of Haematology Princess Alexandra Hospital and University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Opat","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences at Monash Health Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Palfreyman","sequence":"additional","affiliation":[{"name":"Royal Darwin Hospital  Darwin Northern Territory Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N.","family":"Polizzotto","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology The Canberra Hospital  Canberra Australian Capital Territory Australia"},{"name":"Clinical Hub for Interventional Research The Australian National University  Canberra Australian Capital Territory Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Ratnasingam","sequence":"additional","affiliation":[{"name":"St John of God Hospital Geelong  Geelong Victoria Australia"},{"name":"University Hospital Geelong  Geelong Victoria Australia"},{"name":"School of Medicine, Geelong Clinical School Deakin University  Geelong Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology The Royal Melbourne Hospital and The Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Department of Medicine University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Soosapilla","sequence":"additional","affiliation":[{"name":"Flow Cytometry Healius Pathology  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6766-8345","authenticated-orcid":false,"given":"Dipti","family":"Talaulikar","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Genomics, ACT Pathology Canberra Health Services  Canberra Australian Capital Territory Australia"},{"name":"Department of Haematology, ACT Pathology Canberra Health Services  Canberra Australian Capital Territory Australia"},{"name":"Australian National University  Canberra Australian Capital Territory Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9759-5017","authenticated-orcid":false,"given":"Constantine S.","family":"Tam","sequence":"additional","affiliation":[{"name":"Alfred Hospital and Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Weinkove","sequence":"additional","affiliation":[{"name":"Te Rerenga Ora Blood &amp; Cancer Centre Te Whatu Ora Health New Zealand Capital Coast &amp; Hutt Valley  Wellington New Zealand"},{"name":"Cancer Immunotherapy Programme Malaghan Institute of Medical Research  Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Wight","sequence":"additional","affiliation":[{"name":"Department of Haematology and Bone Marrow Transplantation Townsville University Hospital  Townsville Queensland Australia"},{"name":"James Cook University, School of Medicine  Townsville Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Mulligan","sequence":"additional","affiliation":[{"name":"Royal North Shore Hospital  Sydney New South Wales Australia"},{"name":"Healius Pathology  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,9,24]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph181910255"},{"key":"e_1_2_11_3_1","unstructured":"National Health and Medical Research Council.NHMRC Levels of Evidence and Grades for Recommendations for Guideline Developers. [Internet]. National Health and Medical Research Council; 2009. Available from URL:https:\/\/www.nhmrc.gov.au\/_files_nhmrc\/file\/guidelines\/developers\/nhmrc_levels_grades_evidence_120423.pdf"},{"key":"e_1_2_11_4_1","volume-title":"Australian Cancer Incidence and Mortality (ACIM) Books: Chronic Lymphocytic Leukaemia [Internet]","author":"Australian Institute of Health and Welfare (AIHW)","year":"2021"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199109103389"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382104"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0747-7"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010845"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_2_11_10_1","unstructured":"SwerdlowSH CampoE HarrisNL JaffeES.World health organization classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edn.IARC Lyon;2017."},{"key":"e_1_2_11_11_1","first-page":"185","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 4.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Wierda WG","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21595"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_2_11_14_1","first-page":"1","article-title":"Monoclonal B\u2010cell lymphocytosis \u2013 a review of diagnostic criteria, biology, natural history, and clinical management","volume":"29","author":"Tang C","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.012"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15460"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15247"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30163-X"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24808"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2008.080033"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2018.07.004"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2019.07.006"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.190132"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.187583"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.239947"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-873083"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1995.tb06377.x"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812836"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014960"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815281"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313984"},{"key":"e_1_2_11_34_1","first-page":"845","article-title":"First\u2010line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open\u2010label, randomised, phase 3, non\u2010inferiority trial","volume":"4846","author":"Eichhorst B","year":"2016","journal-title":"Lancet Oncol"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30788-5"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-153146"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00293-5"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148457"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-879429"},{"key":"e_1_2_11_41_1","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200006","article-title":"Fixed\u2010duration Ibrutinib\u2010venetoclax in patients with chronic lymphocytic leukemia and comorbidities","volume":"1","author":"Kater AP","year":"2022","journal-title":"NEJM Evid"},{"key":"e_1_2_11_42_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2020-135922","article-title":"Efficacy and safety of front\u2010line venetoclax and rituximab (VenR) for the treatment of Young patients with chronic lymphocytic leukemia and an unfavorable biologic profile. Preliminary results of the Gimema study \u2018Veritas","volume":"136","author":"Mauro FR","year":"2020","journal-title":"Blood"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-850461"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761973"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01181"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61381-5"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-651125"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-667675"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000336"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00144-4"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213093"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-152319"},{"key":"e_1_2_11_53_1","unstructured":"EichhorstB NiemannC KaterA.Time\u2010limited venetoclax\u2010obinutuzumab +\/\u2010 ibrutinib is superior chemoimmunotherapy in frontline chronic lymphocytic leukaemia (CLL): PFS co\u2010primary endpoint of the randomised phase 3 GAIA\/CLL13 trial. 2022 EHA Congress; 2022 Jun 9; Vienna Austria."},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014488"},{"key":"e_1_2_11_55_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/blood-2022-160338","article-title":"Treatment outcomes after undetectable MRD with first\u2010line Ibrutinib (Ibr) plus venetoclax (Ven): fixed duration treatment (placebo) versus continued Ibr with up to 5\u2009years median follow\u2010up in the CAPTIVATE study","volume":"140","author":"Allan JN","year":"2022","journal-title":"Blood"},{"key":"e_1_2_11_56_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2020-134431","article-title":"Long\u2010term efficacy of first\u2010line Ibrutinib treatment for chronic lymphocytic leukemia (CLL) with 4\u2009years of follow\u2010up in patients with TP53 aberrations (del(17p) or TP53 mutation): a pooled analysis from 4 clinical trials","volume":"136","author":"Allan JN","year":"2020","journal-title":"Blood"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2005943"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279012"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.259432"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-763003"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.6840"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004492"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.019"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00465-9"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30671-4"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03355"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2856"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25638"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146570"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00510"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018028761"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215637"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0098"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.2282"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.07.081"},{"key":"e_1_2_11_79_1","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-147599","article-title":"Pirtobrutinib, a next generation, highly selective, non\u2010covalent BTK inhibitor in previously treated CLL\/SLL: updated results from the phase 1\/2 BRUIN study","volume":"138","author":"Mato AR","year":"2021","journal-title":"Blood"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx031"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315226"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002118"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3061"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30196-0"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3815"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001956"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004782"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008502"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000160"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021015014"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005083"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01156-x"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2018.1407645"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18014"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017814"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29438"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902856824"},{"key":"e_1_2_11_98_1","volume-title":"Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia","author":"National Blood Authority","year":"2012"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008073"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13754"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1159\/000514071"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1975.03250030023012"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.5398"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.957203"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1620941"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.4.1165"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17337"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.366"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1349903"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.1305"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.9348"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.29"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01241-1"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.313"},{"key":"e_1_2_11_115_1","unstructured":"AIHW.Indigenous Life Expectancy and Deaths [Internet]. Available from URL:https:\/\/www.aihw.gov.au\/reports\/australias-health\/indigenous-life-expectancy-and-deaths"},{"key":"e_1_2_11_116_1","volume-title":"Cancer: New Registrations and Deaths 2013","author":"Ministry of Health","year":"2016"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.16207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T22:10:48Z","timestamp":1695593448000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.16207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":115,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1111\/imj.16207"],"URL":"https:\/\/doi.org\/10.1111\/imj.16207","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"2022-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}